Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Fuji
Johnson and Johnson
Boehringer Ingelheim
McKinsey
Medtronic
Chinese Patent Office
Baxter

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011270

« Back to Dashboard

NDA 011270 describes FUROXONE, which is a drug marketed by Shire and is included in two NDAs. Additional details are available on the FUROXONE profile page.

The generic ingredient in FUROXONE is furazolidone. There are three drug master file entries for this compound. Additional details are available on the furazolidone profile page.
Summary for 011270
Tradename:FUROXONE
Applicant:Shire
Ingredient:furazolidone
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
QuintilesIMS
Federal Trade Commission
Accenture
UBS
Cerilliant
Express Scripts
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.